Cargando…

A Comparative Analysis of Biomarker Expression and Molecular Subtypes of Pure Ductal Carcinoma In Situ and Invasive Breast Carcinoma by Image Analysis: Relationship of the Subtypes with Histologic Grade, Ki67, p53 Overexpression, and DNA Ploidy

There is a paucity of data regarding molecular subtypes of pure ductal carcinoma in situ (pDCIS). We evaluated the expression of ER, PR, HER2, Ki67, and p53 and DNA ploidy in 118 pDCIS and 100 invasive breast carcinomas (IBCAs) by routine IHC and classified them according to molecular subtypes. Quan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarode, Venetia R., Han, Jeong S., Morris, Danielle H., Peng, Yan, Rao, Roshni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262571/ https://www.ncbi.nlm.nih.gov/pubmed/22295212 http://dx.doi.org/10.4061/2011/217060

Ejemplares similares

Assessment of Ki-67 proliferation index with deep learning in DCIS (ductal carcinoma in situ)
por: Fulawka, Lukasz, et al.
Publicado: (2022)

Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ
por: Jiang, YunQing, et al.
Publicado: (2014)

Molecular subtyping of ependymoma and prognostic impact of Ki-67
por: Lim, Ka Young, et al.
Publicado: (2021)

DNA Sequence Copy Number Aberrations Associated with Histological Subtypes and DNA Ploidy in Gastric Carcinoma
por: Kong, Gu, et al.
Publicado: (2001)

Ductal Carcinoma In Situ of the Breast: Perspectives on Tumor Subtype and Treatment
por: Liu, Yufei, et al.
Publicado: (2020)

Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki 67 expression in renal cell carcinoma.
por: Wada, Y., et al.
Publicado: (1998)

Can Histological Grade and Mitotic Index Replace Ki67 to Determine Luminal Breast Cancer Subtypes?
por: Oddó, David, et al.
Publicado: (2018)

Immunohistochemical expression of p53, Ki67, α-SMA, CD44 and CD31 in different histological subtypes of basal cell carcinoma
por: Cojocaru, Anca, et al.
Publicado: (2022)

Semi-automated evaluation of Ki-67 index in invasive ductal carcinoma of the breast
por: SUCIU, CRISTIAN, et al.
Publicado: (2014)

The Effect of Black Cohosh on Ki67 expression and Tumor Volume: A Pilot Study of Ductal Carcinoma in Situ Patients
por: Trant, Amelia A., et al.
Publicado: (2022)

Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype
por: Hermans, B C M, et al.
Publicado: (2019)

An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
por: Behbod, Fariba, et al.
Publicado: (2009)

Pre-operative Prediction of Ki-67 Expression in Various Histological Subtypes of Lung Adenocarcinoma Based on CT Radiomic Features
por: Huang, Zhiwei, et al.
Publicado: (2021)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
por: Stathopoulos, George P., et al.
Publicado: (2014)

Ki-67 as a prognostic marker according to breast cancer molecular subtype
por: Soliman, Nahed A., et al.
Publicado: (2016)

Hormone Receptor Subtype in Ductal Carcinoma in Situ: Prognostic and Predictive Roles of the Progesterone Receptor
por: Hwang, Ki‐Tae, et al.
Publicado: (2021)

Molecular subtyping reveals uniqueness of prognosis in breast ductal carcinoma in situ patients with lumpectomy
por: Yang, Libo, et al.
Publicado: (2022)

Effect of Ki-67 Expression Levels and Histological Grade on Breast Cancer Early Relapse in Patients with Different Immunohistochemical-based Subtypes
por: Liang, Qin, et al.
Publicado: (2020)

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
por: Rakovitch, E, et al.
Publicado: (2012)

Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
por: Millis, R R, et al.
Publicado: (2004)

Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters
por: Hashmi, Atif Ali, et al.
Publicado: (2019)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
por: Sadeghian, Dorsay, et al.
Publicado: (2022)

Hypoxia-inducible factor-2a is associated with ABCG2 expression, histology-grade and Ki67 expression in breast invasive ductal carcinoma
por: Xiang, Lei, et al.
Publicado: (2012)

Subtypes of high-grade breast ductal carcinoma in situ (DCIS): incidence and potential clinical impact
por: Schandiz, Hossein, et al.
Publicado: (2023)

VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma
por: Park, Seongyeol, et al.
Publicado: (2016)

Ki-67 is overexpressed in human laryngeal carcinoma and contributes to the proliferation of HEp2 cells
por: Bai, Yanxia, et al.
Publicado: (2016)

FIGO staging in ovarian carcinoma and histological subtypes
por: Kehoe, Sean
Publicado: (2020)

Histologic subtyping of ampullary carcinoma for targeted therapy
por: Hong, Seung-Mo
Publicado: (2021)

Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma
por: GADBAIL, Amol Ramchandra, et al.
Publicado: (2021)

Prognostic value of Ki-67 in nasopharyngeal carcinoma: a meta-analysis
por: Li, Yulin, et al.
Publicado: (2021)

Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy
por: Clark, Andrea J., et al.
Publicado: (2016)

Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
por: Zhou, Wenjing, et al.
Publicado: (2013)

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
por: Doebar, Shusma C., et al.
Publicado: (2016)

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery
por: Yang, Yilan, et al.
Publicado: (2022)

Expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in ductal carcinoma in situ (DCIS) and DCIS with microinvasion
por: Wan, Zhi-Bin, et al.
Publicado: (2018)

Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki-67) Markers
por: M. Lopes, José, et al.
Publicado: (1998)

Histologic correlation of expression of Ki-67 in squamous cell carcinoma of the glottis according to the degree of cell differentiation()
por: Bonhin, Rodrigo Gonzalez, et al.
Publicado: (2014)

Racial difference in histologic subtype of renal cell carcinoma
por: Olshan, Andrew F, et al.
Publicado: (2013)

Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance
por: Makki, Jaafar
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q6sva7rv4a57irbsb11oul04js